Congress Acts to Improve CDC and NIH Lyme Disease Programs

The FY 2018 Congressional Appropriations bill signed into law on March 23, 2018 was accompanied by House and Senate Appropriations Committee reports that include more than a dozen directives for the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) to improve their programs for surveillance, prevention, diagnosis, and treatment of Lyme disease.

The Patient Centered Care Advocacy Group worked with other stakeholder organizations to develop a portion of the proposed report language, which was submitted to the House and Senate Appropriations Committees via letters from individual members of Congress. Committee staff reviewed the input and drafted the final language for approval.

Full article: